Fabiola Martin

Summary

Affiliation: Hull York Medical School
Country: UK

Publications

  1. pmc Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada
    Benoit Barbeau
    D├ępartement des Sciences Biologiques and BioMed Research Center, Universite du Quebec a Montreal, Room SB 3335, 2080 St Urbain, Montreal, Quebec, Canada
    Retrovirology 11:19. 2014
  2. pmc Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, United Kingdom
    PLoS Negl Trop Dis 6:e1675. 2012
  3. pmc Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, UK
    Retrovirology 8:86. 2011

Collaborators

  • Benoit Barbeau
  • Edgar Carvalho
  • Edward L Murphy
  • Toshiki Watanabe
  • John Hiscott
  • Kathryn Jones
  • William M Switzer
  • Lee Ratner
  • Ali Bazarbachi
  • Masao Matsuoka

Detail Information

Publications3

  1. pmc Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada
    Benoit Barbeau
    D├ępartement des Sciences Biologiques and BioMed Research Center, Universite du Quebec a Montreal, Room SB 3335, 2080 St Urbain, Montreal, Quebec, Canada
    Retrovirology 11:19. 2014
    ..In this review, highlights of the meeting are provided by different experts for each of these research areas. ..
  2. pmc Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, United Kingdom
    PLoS Negl Trop Dis 6:e1675. 2012
    ..We therefore tested the hypothesis that inhibition of T-cell activation with ciclosporin A would be safe and clinically beneficial in patients with early and/or clinically progressing HAM/TSP...
  3. pmc Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium
    Fabiola Martin
    Centre for Immunology and Infection, Department of Biology, Hull and York Medical School, University of York, York, UK
    Retrovirology 8:86. 2011
    ....